Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: General physical health deterioration/The general well-being deteriorated rapidly; This is a spontaneous report from a non-contactable other healthcare professional downloaded from the Medicines Agency (MA) Regulatory authority-WEB FI-FIMEA-20210542. An 80-year-old female patient receive BNT162B2 (COMIRNATY, lot number was EJ6134 and expiration date was unknown) via intramuscular on 27Jan2021 at single dose for COVID-19 vaccination. Medical history included extensive metastatic pancreas cancer diagnosed in Dec2020, flimmer (atrial fibrillation) and hypertension (HTA). Patient received palliative care policy. Concomitant medication included levothyroxine sodium (THYROXIN) and dalteparin sodium (FRAGMIN). Patient had general physical health deterioration on 27Jan2021. The general well-being deteriorated rapidly from the day of vaccination (27Jan2021), although even before that the general well-being had decreased. The patient died due to general well-being deteriorated on 30Jan2021. It was not reported if an autopsy was performed. The outcome of event was fatal. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: General physical health deterioration/The general well-being deteriorated rapidly
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166